FDA
approval
· 2012-11-28
FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
FDA approved a supplemental application for Exforge (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation. This action updates the appro…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EXFORGE (AMLODIPINE BESYLATE AND VALSARTAN)